NCT00182403View on ClinicalTrials.gov

Fixed Dose Heparin Study

PHASE3CompletedINTERVENTIONAL
Enrollment

866

Participants

Timeline

Start Date

September 30, 1998

Study Completion Date

May 31, 2004

Conditions
Venous ThromboembolismDeep Vein ThrombosisPulmonary Embolism
Interventions
DRUG

UFH 250 U/kg or LMWH 100 U/kg sc twice daily

Trial Locations (8)

L8L 2X2

Hamilton Health Sciences-General Campus, Hamilton

L8N 3Z5

Hamlton Health Sciences -McMaster Campus, Hamilton

L8N 4A6

St. Joseph's Healthcare Centre, Hamilton

L8V 1C3

Hamilton Health Sciences-Henderson Campus, Hamilton

H3G 1A4

McGill University Health Centre, Montreal

Unknown

CHA Pavillon du Saint-Sacrement, Québec

Auckland Hospital, Auckland

Middlemore, Otahuhu

All Listed Sponsors
collaborator

Heart and Stroke Foundation of Ontario

OTHER

lead

McMaster University

OTHER

NCT00182403 - Fixed Dose Heparin Study | Biotech Hunter | Biotech Hunter